|
"kuen feng chen"的相關文件
顯示項目 1-10 / 13 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma
|
Ming-Hung Hu;Tzu-Ting Huang;Tzu-I Chao;Li-Ju Chen;Yen-Lin Chen;Ming-Hsien Tsai;Chun-Yu Liu;Jia-Horng Kao;Kuen-Feng Chen; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
SC-1, a sorafenib derivative, shows anti-tumor effects in osteogenic sarcoma cells
|
Wang, C.-T.;Lin, C.-S.;Shiau, C.-W.;Chu, P.-Y.;Hsiao, C.-C.;Chiang, Y.-L.;Tai, W.-T.;Chen, K.-F.; Wang, C.-T.; Lin, C.-S.; Shiau, C.-W.; Chu, P.-Y.; Hsiao, C.-C.; Chiang, Y.-L.; Tai, W.-T.; Chen, K.-F.; CHEN-SI LIN; Kuen-Feng Chen |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen, K.-F.;Chen, H.-L.;Shiau, C.-W.;Liu, C.-Y.;Chu, P.-Y.;Tai, W.-T.;Ichikawa, K.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:39:53Z |
Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells
|
HSIANG-PO HUANG; Kuen-Feng Chen |
| 臺大學術典藏 |
2018-09-10T09:39:53Z |
Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome
|
Yu, H.-C.;Hou, D.-R.;Liu, C.-Y.;Lin, C.-S.;Shiau, C.-W.;Cheng, A.-L.;Chen, K.-F.; Yu, H.-C.; Hou, D.-R.; Liu, C.-Y.; Lin, C.-S.; Shiau, C.-W.; Cheng, A.-L.; Chen, K.-F.; CHEN-SI LIN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:39:53Z |
Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma
|
Yu, H.-C.;Chen, H.-J.;Chang, Y.-L.;Liu, C.-Y.;Shiau, C.-W.;Cheng, A.-L.;Chen, K.-F.; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:41:21Z |
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
|
Chen, K.-F.;Tai, W.-T.;Huang, J.-W.;Hsu, C.-Y.;Chen, W.-L.;Cheng, A.-L.;Chen, P.-J.;Shiau, C.-W.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen, K.-F. Yu, H.-C. Liu, C.-Y. Chen, H.-J. Chen, Y.-C. Hou, D.-R. Chen, P.-J. Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
|
Chen, K.-F.;Yu, H.-C.;Liu, T.-H.;Lee, S.-S.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG; SHOEI-SHENG LEE |
顯示項目 1-10 / 13 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
